Search research articles
Contact Us
Filters
Showing results (41-50 of 91) with videos related to
Page
of 10
Sort By:
Journal for Immunotherapy of Cancer
|
July 24, 2021
Antiviral antibody responses to systemic administration of an oncolytic RNA virus: the impact of standard concomitant anticancer chemotherapies
Victoria Roulstone, David Mansfield, Robert J Harris, et al.
Cancer Research
|
December 20, 2007
Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer
Timothy Kottke, Luis Sanchez-Perez, Rosa Maria Diaz, et al.
The Journal of Clinical Investigation
|
April 6, 2010
Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice
Timothy Kottke, Geoff Hall, Jose Pulido, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 27, 2014
Phase I trial of cyclophosphamide as an immune modulator for optimizing oncolytic reovirus delivery to solid tumors
Victoria Roulstone, Khurum Khan, Hardev S Pandha, et al.
Nature Medicine
|
August 20, 2003
A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines
Vy Phan, Fiona Errington, S Chiat Cheong, et al.
Experimental Cell Research
|
May 1, 2007
The inhibition of TNF-alpha anti-tumoral properties by blocking antibodies promotes tumor growth in a rat model
Nicolas Larmonier, Dominique Cathelin, Claire Larmonier, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 3, 2020
Vesicular Stomatitis Virus Encoding a Destabilized Tumor Antigen Improves Activation of Anti-tumor T Cell Responses
Amanda L Huff, Laura Evgin, Jill Thompson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 28, 2015
Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses
Karishma Rajani, Christopher Parrish, Timothy Kottke, et al.
Plastic and Reconstructive Surgery
|
January 29, 2015
Adenovirally delivered enzyme prodrug therapy with herpes simplex virus-thymidine kinase in composite tissue free flaps shows therapeutic efficacy in rat models of glioma
Rohit Seth, Aadil A Khan, Timothy D Pencavel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 28, 2011
Precise scheduling of chemotherapy primes VEGF-producing tumors for successful systemic oncolytic virotherapy
Timothy Kottke, John Chester, Elizabeth Ilett, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 91) with videos related to
Sort By:
Page
of 10
Journal for Immunotherapy of Cancer
|
July 24, 2021
Antiviral antibody responses to systemic administration of an oncolytic RNA virus: the impact of standard concomitant anticancer chemotherapies
Victoria Roulstone, David Mansfield, Robert J Harris, et al.
Cancer Research
|
December 20, 2007
Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer
Timothy Kottke, Luis Sanchez-Perez, Rosa Maria Diaz, et al.
The Journal of Clinical Investigation
|
April 6, 2010
Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice
Timothy Kottke, Geoff Hall, Jose Pulido, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 27, 2014
Phase I trial of cyclophosphamide as an immune modulator for optimizing oncolytic reovirus delivery to solid tumors
Victoria Roulstone, Khurum Khan, Hardev S Pandha, et al.
Nature Medicine
|
August 20, 2003
A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines
Vy Phan, Fiona Errington, S Chiat Cheong, et al.
Experimental Cell Research
|
May 1, 2007
The inhibition of TNF-alpha anti-tumoral properties by blocking antibodies promotes tumor growth in a rat model
Nicolas Larmonier, Dominique Cathelin, Claire Larmonier, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 3, 2020
Vesicular Stomatitis Virus Encoding a Destabilized Tumor Antigen Improves Activation of Anti-tumor T Cell Responses
Amanda L Huff, Laura Evgin, Jill Thompson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 28, 2015
Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses
Karishma Rajani, Christopher Parrish, Timothy Kottke, et al.
Plastic and Reconstructive Surgery
|
January 29, 2015
Adenovirally delivered enzyme prodrug therapy with herpes simplex virus-thymidine kinase in composite tissue free flaps shows therapeutic efficacy in rat models of glioma
Rohit Seth, Aadil A Khan, Timothy D Pencavel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 28, 2011
Precise scheduling of chemotherapy primes VEGF-producing tumors for successful systemic oncolytic virotherapy
Timothy Kottke, John Chester, Elizabeth Ilett, et al.
Page
of 10